Phase 1 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Healthy volunteers with a BMI between 18 and 39.9 (the trial is looking for people across four weight ranges: normal weight, overweight, grade 1 obesity, and grade 2 obesity)
- People whose kidneys are working at a sufficient level (a kidney function score above 50 ml/min, as measured by a specific test — confirm with trial site)
- People with good, accessible veins suitable for blood sample collection
- Women who are either using contraception or who have gone through menopause
- People who are able to give written consent and are enrolled in the public health insurance system
Who may not be able to join:
- People taking certain medications that could affect the kidneys or interact with the study drug, including diuretics (water pills), anti-inflammatory painkillers (such as ibuprofen), or statins (cholesterol-lowering drugs)
- People who have had a serious allergic reaction to any medication (such as severe swelling) or who have significant organ problems such as liver failure or heart failure
- People who have diabetes or who take diabetes medications
- People who have high blood pressure or who take blood pressure medications
- People taking medications that are known to interact with the study drug acyclovir, including certain stomach acid medications, Probenecid, Mycophenolate Mofetil, Lithium, or immune-suppressing drugs such as Ciclosporin or Tacrolimus
- People currently taking blood-thinning medications (anticoagulants)
- People who have a known allergy or sensitivity to acyclovir
- People who are pregnant
- People who have taken part in another clinical study within the last two months
- People who currently have an active HSV or VZV viral infection (such as cold sores, genital herpes, or shingles) being treated with acyclovir
- Adults who are under legal guardianship, any other form of legal protection, or who are restricted in their freedom by a court or government decision
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarah Baklouti, PharmD, University Hospital, Toulouse
Phone: 05 67 69 03 83
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Renal elimination clearance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.